The Centers for Medicare and Medicaid Services proposed Tuesday to let Medicare cover monoclonal antibodies as an Alzheimer’s treatment Aduhelm in the context of clinical studies.
The coverage designation allows Medicare to cover the controversial Alzheimer’s drug Aduhelm when used in clinical…